Yorlabs — Stock, Pipeline & Market Cap

Is this your company? Claim your profile to update info and connect with investors.

Private Company

Funding information not available

Overview

YorLabs is a private, pre-revenue medical device startup targeting the interventional cardiology and electrophysiology imaging market with a novel ICE system. The company's value proposition centers on a capital-efficient, zero-footprint platform intended to reduce procedural complexity, cognitive load, and environmental impact while improving hospital economics. Led by a team with extensive medical device and startup experience, YorLabs is seeking investment to advance development and commercialization of its technology.

Cardiovascular

Technology Platform

Zero-footprint, zero CapEx intracardiac echocardiography (ICE) system designed for single-operator control during interventional cardiology and electrophysiology procedures.

Opportunities

The growing volume of minimally invasive cardiac procedures and hospital demand for capital-efficient, workflow-enhancing technologies create a significant market entry opportunity.

YorLabs' zero-CapEx model could disrupt the traditional capital sales cycle and accelerate adoption in cost-conscious healthcare environments.

Risk Factors

Key risks include failure to secure regulatory clearance (FDA/CE Mark), challenges in commercial execution against entrenched competitors with vast resources, and the inherent difficulty of changing established physician workflows and hospital purchasing patterns in a conservative industry.

Competitive Landscape

YorLabs competes against large, diversified medical imaging corporations like Philips, Siemens Healthineers, and GE HealthCare, which offer ICE systems but are criticized for sub-optimal workflow integration in IC/EP. Competition also includes other specialized ICE players and integrated solutions from ablation catheter manufacturers.

More companies in Diagnostics & Precision Medicine →More companies in United States →